Nimodipine

Allen GS, Ahn HS, Preziosi JT, Battye R, et al. Cerebral arterial spasm: a controlled trial of nimodipine in patients with subarachnoid hemorrhage. New England Journal of Medicine 308: 619–624, 1983 American Nimodipine Study Group. Clinical trial of nimodipine in acute ischaemic stroke. Stroke 23: 3–8, 1992 Ameriso SF, Wenby RB, Meiselman HJ, Fisher M. Nimodipine and the evolution of hemorheological variables after acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases 2: 22–25, 1992 Auer LM. Acute operation and preventive nimodipine improve outcome in patients with ruptured cerebral aneurysms. Neurosurgery 15: 57–66, 1984 Auer LM, Oberbauer RW, Schalk HV. Human pial vascular reactions to intravenous nimodipine-infusion during EC-IC bypass surgery. Stroke 14: 210–213, 1983 Bailey I, Bell A, Gray J, Gullan R, Heiskanan O, et al. A trial of the effect of nimodipine on outcome after head injury. Acta Neurochirurgica 110: 97–105, 1991 Ban TA, Morey L, Aguglia E, Azzarelli O, Balsano F, et al. Nimodipine in the treatment of old age dementias. Progress in Neuro-Psychopharmacology and Biological Psychiatry 14: 525–551, 1990 Baumel B, Eisner LS, Karukin M, MacNamara R, Raphan H. Nimodipine in the treatment of Alzheimer’s disease. In Bergener & Reisberg (Eds) Diagnosis and treatment of senile dementia, pp 366–373, Springer-Verlag, Berlin, Heidleberg, 1989 Bianchi AP, Viglianesi MS. Hemorheological effects of dihydropyridine calcium entry blockers. Abstract. Naunyn-Schmiedeberg’s Archives of Pharmacology 330 (Suppl. V): R37, 1985 Bielenberg GW, Stierstorfer H-J, Weber J, Kreiglstein J. Nimodipine reduces postischemic lactate levels in the isolated perfused rat brain. Biochemical Pharmacology 38: 853–855, 1989 Bielenberg GW, Burniol M, Rösen R, Klaus W. Effects of nimodipine on infarct size and cerebral acidosis after middle cerebral artery occlusion in the rat. Stroke 21 (Suppl. IV): IV90–IV92, 1990 Bogousslavsky J, Regli F, Zumstein V, Köbberling W. Double-blind study of nimodipine in non-severe stroke. European Neurology 30: 23–26, 1990 Bormann B, v. Boldt J, Kling D, Mulch J, Weidler B, et al. Influence of nimodipine on cardiovascular parameters during coronary surgery. Neurochirurgia 28: 79–83, 1985 Bogousslavsky J, Regli F, Zumstein V, Köbberling W. Double-blind study of nimodipine in non-severe stroke. European Journal of Neurology 30: 23–26, 1990 Canadè V, Catapano F, Muraca L, Cosentino A. Effect of nimodipine on mental deterioration in subjects affected by chronic cerebro-vascular diseases. Minerva Medica 82: 111–114, 1991 Cummings JL, Jarvik LF. Dementia. In Cassel CK et al. (Eds) Geriatric medicine, 2nd ed., pp. 428–448, Springer-Verlag, New York, 1990 Dorsch NWC. Subarachnoid haemorrhage. Medical Journal of Australia 154: 505–506, 1991 Dorsch NWC, Branston NM, Harris RJ, Bentivoglio P, Symon L. An experimental study of the effect of nimodipine in primate subarachnoid haemorrhage. Acta Neurochirurgica 99: 65–75, 1989 Engel RR, Satzger W. Methodological problems in assessing therapeutic efficacy in patients with dementia. Drugs & Aging 2: 79–85, 1992 Fischhof PK, Wagner G, Littschauer L, Rüther E, Apecechea M, et al. Therapeutic results with nimodipine in primary degenerative dementia and multi-infarct dementia. In Bergener & Reisberg (Eds) Diagnosis and treatment of senile dementia, pp 350–359, Springer-Verlag, Berlin, Heidelberg, 1989 Forsman M, Olsnes BT, Semb G, Steen PA. Effects of nimodipine on cerebral blood flow and neuropsychological outcome after cardiac surgery. British Journal of Anaesthesia 1990 65: 514–520, 1990 Gaab MR, Haubitz I, Brawanski A, Korn A, Czech Th. Acute effects of nimodipine on the cerebral blood flow and intracranial pressure. Neurochirurgia 28: 93–99, 1985 Gelmers HJ. Effect of nimodipine (Bay e 9736) on postischaemic cerebrovascular reactivity, as revealed by measuring regional cerebral blood flow (rCBF). Acta Neurochirurgica 63: 283–290, 1982 Gelmers HJ. The effects of nimodipine on the clinical course of patients with acute ischemic stroke. Acta Neurologica Scandinavica 69: 232–239, 1984 Gelmers HJ, Goiter K, de Weerdt CJ, Wiezer HJA. A controlled trial of nimodipine in acute ischemic stroke. New England Journal of Medicine 318: 203–207, 1988 Gelmers HJ, Hennerici M. Effect of nimodipine on acute ischemic stroke: pooled results from five randomized trials. Stroke 21 (Suppl. IV): IV81–IV84, 1990 Gengo FM, Fagan SC, Krol G, Bernhard H. Nimodipine disposition and haemodynamic effects in patients with cirrhosis and age-matched controls. British Journal of Clinical Pharmacology 23: 47–53, 1987 Gilsbach JM, Harders AG. Morbidity and mortality after early aneurysm surgery: a prospective study with nimodipine prevention. Acta Neurochirurgica 96: 1–7, 1989 Gilsbach JM, Reulen HJ, Ljunggren B, Brandt L, v Holst H, et al. Early aneurysm surgery and preventive therapy with intravenously administered nimodipine: a multicenter, double-blind, dose-comparison study. Neurosurgery 26: 458–464, 1990 Grabowski M, Johansson BB. Nifedipine and nimodipine: effect on blood pressure and regional cerebral blood flow in conscious normotensive and hypertensive rats. Journal of Cardiovascular Pharmacology 7: 1127–1133, 1985 Greenberg JH, Uematsu D, Araki N, Hickey WF, Reivich M. Cytosolic free calcium during focal cerebral ischemia and the effects of nimodipine on calcium and histologic damage. Stroke 21 (Suppl. IV): IV72–IV77, 1990 Gueugniaud P-Y, Gaussorgues P, Garcia-Darennes F, Bancalari G, Roux H, et al. Early effects of nimodipine on intracanial and cerebral perfusion pressures in cerebral anoxia after out-of-hospital cardiac arrest. Resuscitation 20: 203–212, 1990 Hakim AM, Hogan MJ. In vivo binding of nimodipine in the brain. I. The effect of focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 11: 762–770, 1991 Hakim AM, Pokrupa RP, Villanueva J, Diksic M, Evans AC, et al. The effect of spontaneous reperfusion on metabolic function in early human cerebral infarcts. Annals of Neurology 21: 279–289, 1987 Hakim AM, Evans AC, Berger L, Kuwabara H, Worsley K, et al. The effect of nimodipine on the evolution of human cerebral infarction studied by PET. Journal of Cerebral Blood Flow and Metabolism 9: 523–534, 1989 Hara H, Onodera H, Nagasawa H, Kogure K. Effect of nimodipine on ischemia-induced brain edema and mortality in a novel transient middle cerebral artery occlusion model. Japanese Journal of Pharmacology 53: 247–253, 1990 Harper AM, Craigen L, Kazda S. Effect of the calcium antagonist, nimodipine, on cerebral blood flow and metabolism in the primate. Journal of Cerebral Blood Flow and Metabolism 1: 349–356, 1981 Harris RJ, Branston NM, Symon L, Bayhan M, Watson A. The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia. Stroke 13: 759–766, 1982 Haws CW, Gourley JK, Heistad DD. Effects of nimodipine on cerebral blood flow. Journal of Pharmacology and Experimental Therapeutics 225: 24–28, 1983 Heiss W-D, Holthoff V, Pawlik G, Neveling M. Effect of nimodipine on regional cerebral glucose metabolism in patients with acute ischemic stroke as measured by positron emission tomography. Journal of Cerebral Blood Flow and Metabolism 10: 127–132, 1990 Hilgert D, Eicher H, Liebl D, Platt D, Becker C, et al. Nimodipin-Therapie multimorbider geriatrischer Patienten mit hirnorganischem psychosyndrom — Pharmakodynamik und kinetik. Medizinische Welt 43: 20–26, 1992 Hogan M, Gjedde A, Hakim AM. Nimodipine binding in focal cerebral ischemia. Stroke 21 (Suppl. IV): IV78–IV80, 1990 Holthoff V, Beil C, Hartmann-Klosterkötter U, Neveling M, Pawlik G, et al. Effect of nimodipine on glucose metabolism in the course of ischemic stroke. Stroke 21 (Suppl. IV): IV95–IV97, 1990 Hunt WE, Hess RH. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. Journal of Neurosurgery 28: 14–20, 1968 Huyghens LP, Buylaert WA, Corne L, Rosseel MT, Bogaert MG. Plasma concentrations and haemodynamic effects of nimodipine in patients resuscitated after cardiac arrest. European Journal of Clinical Pharmacology 36: 327–333, 1989 Jacewicz M, Brint S, Tanabe J, Pulsinelli WA. Continuous nimodipine treatment attenuates cortical infarction in rats subjected to 24 hours of focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 10: 89–96, 1990 James IM, Savage IT. Nimodipine on cerebral blood flow and altertness in man. In Lechner & Ladurner (Eds) Progress in pathophysiology, diagnosis and therapy of cerebrovascular diseases. pp. 142–149, Excerpta Medica, 1984 Jan M, Buchheit F, Tremoulet M. Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Neurosurgery 23: 154–157, 1988 Jansen I, Tfelt-Hansen P, Edvinsson L. Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders. European Journal of Clinical Pharmacology 40: 7–15, 1991 Juvela S, Kaste M, Hillbom M. Effect of nimodipine on platelet function in patients with subarachnoid hemorrhage. Stroke 21: 1283–1288, 1990 Juvela S, Öhman J, Servo A, Heiskanen O, Kaste M. Angiographic vasospasm and release of platelet thromboxane after subarachnoid hemorrhage. Stroke 22: 451–455, 1991 Kamath B, Lettieri J, Krol G, Raemusch K, Yeh S, et al. Phar-macokinetics and metabolism of radiolabeled nimodipine. Pharmacological Research 4 (Suppl. 2): S80, 1987 Kanowski S, Fischhof P, Hiersemenzel J, Röhmel J, Kern U. Therapeutic efficacy of nootropic drugs — a discussion of clinical phase III studies with nimodipine as a model. In Bergener & Reisberg (Eds) Diagnosis and treatment of senile dementia, pp. 339–349, Springer-Verlag, Berlin, Heidelberg, 1989 Kapoula O, Lehrl S, Fischer B, Burkard G, Schuback G. Nimodipin bei Hirnleistungsstörungen im Alter — eine placebokontrollierte Doppelblindstudie in ärztlichen Praxen. Geriatrie & Rehabilitation 3: 135–146, 1990 Kazda S, Garthoff B, Krause HP, Schlossmann K. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments. Arzneimittel-Forschung 32: 331–338, 1982 Kanda K, Flaim SF. Effects of nimodipine on cerebral blood flow in conscious rat. Journal of Pharmacology and Experimental Therapeutics, 236: 41–47, 1986 Kirch W, Rämsch KD, Dührsen U, Ohnhaus EE. Clinical pharmacokinetics of nimodipine in normal and impaired renal function. International Journal of Clinical Pharmacology Research IV: 381–384, 1984 Koos WT, Perneczky A, Auer LM, Böker DK, Gaab M, et al. Nimodipine treatment of ischemic neurological deficits due to cerebral vasospasm after subarachnoid hemorrhage. Neurochirurgia 28: 114–117, 1985 Kosnik EJ, Hunt WE. Postoperative hypertension in the management of patients with intracranial arterial aneurysms. Journal of Neurosurgery 45: 148–154, 1976 Kraaier V, van Huffelen AC, Wieneke GH, Keppel Hesselink JM. Nimodipine tested in a human model of cerebral ischaemia: electroencephalographic and transcranial Doppler ultrasound investigations in normal subjects during standardized hyperventilation. European Journal of Clinical Pharmacology 40: 17–21, 1991 Krol GJ, Noe AJ, Yeh SC. Gas and liquid Chromatographic analyses of nimodipine calcium antagonist in blood plasma and cerebrospinal fluid. Journal of Chromatography 305: 105–118, 1984 Langley MS, Sorkin EM. Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 37: 669–699, 1989 Lenz P, Luckhaus G, Stasch J-P, Kazda S. Therapy of diseased stroke-prone spontaneously hypertensive rats with nimodipine. Stroke 21 (Suppl. IV): IV111–IV112, 1990 Lewis PJ, Weir BKA, Nosko MG, Tanabe T, Grace MG. Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Neurosurgery 22: 492–500, 1988 Ljunggren B, Brandt L, Säveland H, Nilsson PE, Cronqvist S, et al. Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine. Journal of Neurosurgery 61: 864–873, 1984 Ljunggren B, Brandt L, Säveland H. Management of aneurysmal subarachnoid hemorrhage. In Vincent JL (Ed.). Update in intensive care and emergency medicine, pp. 179–184, Springer Verlag, Berlin, 1985 Martínez-Vila E, Guillén F, Villanueva JA, Matías-Guíu J, Bigorra J, et al. Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction. Stroke 21: 1023–1028, 1990 McCalden TA, Nath RG, Thiele K. The effects of a calcium antagonist (nimodipine) on basal cerebral blood flow and reactivity to various agonists. Stroke 15: 527–530, 1984 Mee E, Dorrance D, Lowe D, Neil-Dwyer G. Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 22: 484–491, 1988 Melina D, Guerrera G, Colivicchi F, Santoliquido A, Cardillo C, et al. Anthihypertensive effect of nimodipine in elderly patients with chronic cerebrovascular disease: a preliminary report. Current Therapeutic Research 48: 70–80, 1990 Meyer H, Wehinger E, Bossert F, Scherling D. Nimodipine: synthesis and metabolic pathway. Arzneimittel-Forschung 33(I): 106–112, 1983 Mohamed AA, McCulloch T, Mendelow AD, Teasdale GM, Harper AM. Effect of the calcium antagonist nimodipine on local cerebral blood flow: relationship to arterial pressure. Journal of Cerebral Blood Flow and Metabolism 4: 206–211, 1984 Mück W, Wingender W, Seiberling M, Woelke E, Rämsch K-D, et al. Influence of the H2-receptor antagonists cimetidine and ranitidine on the pharmacokinetics of nimodipine in healthy volunteers. European Journal of Clinical Pharmacology 42: 325–328, 1992 Murphy JJ. The role of calcium antagonists in the treatment of cerebrovascular disease. Drugs & Aging 2: 1–6, 1992 Newberg Milde L, Milde JH, Michenfelder JP. Delayed treatment with nimodipine improves cerebral blood flow after complete cerebral ischaemia in the dog. Journal of Cerebral Blood Flow and Metabolism 6: 332–337, 1986 Öhman J, Heiskanen O. Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. Journal of Neurosurgery 69: 683–686, 1988 Öhman J, Servo A, Heiskanen O. Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. Journal of Neurosurgery 74: 8–13, 1991 Onoda JM, Sloane BF, Honn V, Honn KV, et al. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors. Thrombosis Research 34: 367–378, 1984 Petruk KC, West M, Mohr G, Weir BKA, Benoit BG, et al. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. Journal of Neurosurgery 68: 505–517, 1988 Philippon BL, Chacornac R, Salord F, Kayayan R. FCBF Study of the effects of two calcium blockers during subarachnoid hemorrhage. Stroke 21 (Suppl. 8): 1129, 1990 Philipon J, Grob R, Dagreou F, Guggiari M, Rivierez M, et al. Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochirurgica 82: 110–114, 1986 Pickard JD, Murray GD, Illingworth R, Shaw MDM, Teasdale GM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. British Medical Journal 298: 636–642, 1989 Pickard JD, Murray GD, Illingworth R, Shaw MDM, Teasdale GM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. British Medical Journal 298: 33–59, 1989 Pittera A, Ciancitto S. Effect of oral nimodipine on cerebral blood flow in patients with chronic cerebrovascular disorders: a supra-aortic Doppler ultrasound open study. Current Therapeutic Research 48: 716–729, 1990 Politi GC, Romanini BM, Belloli PA, Rossi A, Bellaviti N, et al. The use of nimodipine (Nimotop-Bayer) in patients with chronic ischemic cerebral vasculopathies. Twenty-eight case reports. Panminerva Medica 32: 85–87, 1990 Powell M. Subarachnoid haemorrhage. Prescriber’s Journal 30: 173–179, 1990 Pozzilli C, DiPiero V, Pantano P, Rasura M, Lenzi GL. Influence of nimodipine on cerebral blood flow in human cerebral ischaemia. Journal of Neurology 236: 199–202, 1989 Rämsch K-D, Ahr G, Tettenborn D, Auer LM. Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage. Neurochirurgia 28: 74–78, 1985a Rämsch K-D, Graefe K-H, Sommer J. Pharmacokinetics and metabolism of nimodipine. In Betz et al. (Eds) Nimodipine: pharmacological and clinical properties, pp. 147–161 Schattauer Verlag. Stuttgart, 1985b Rämsch K-D, Lücker PW, Wetzelsburger N. Pharmacokinetics of intravenously and orally administered nimodipine. Clinical Pharmacology and Therapeutics 41: 216, 1987 Rämsch K-D, Graefe K-H, Scherling D, Sommer J, Ziegler R. Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine and nimodipine. American Journal of Nephrology 6: 73–80, 1986 Robinson MJ, Teasdale GM. Calcium antagonists in the management of subarachnoid haemorrhage. Cerebrovascular and Brain Metabolism Reviews 2: 205–226, 1990 Roine RO, Kaste M, Kinnunen A, Nikki P, Sarna S, et al. Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial. Journal of the American Medical Association 264: 3171–3177, 1990 Rudin M, Sauter A. Dihydropyridine calcium antagonists reduce the consumption of high-energy phosphates in the rat brain. A study using combined P/H magnetic resonance spectroscopy and P saturation transfer. Journal of Pharmacology and Experimental Therapeutics 251: 700–706, 1989 Sahlin Ch, Owman Ch, Chang J-Y, Delgado T, Salford LG, et al. Changes in contractile response and effect of a calcium antagonist, nimodipine, in isolated intracranial arteries of baboon following experimental subarachnoid hemorrhage. Brain Research Bulletin 24: 355–361, 1990 Sauter A, Rudin M, Wiederhold K-H, Hof RP. Cerebrovascular, biochemical and cytoprotective effects of isradipine in laboratory animals. American Journal of Medicine 86 (Suppl. 4A): 134–146, 1989 Sauter A, Rudin M. Calcium antagonists for reduction of brain damage in stroke. Journal of Cardiovascular Pharmacology 15 (Suppl. 1): S43–S47, 1990 Säveland H, Ljunggren B, Brandt L, Messeter K. Delayed ischemic deterioration in patients with early aneurysm operation and intravenous nimodipine. Neurosurgery 18: 146–150, 1986 Schmage N, Boehme K, Dycka J, Schmitz H. Nimodipine for psychogeriatric use: methods, strategies, and considerations based on experience with clinical trials. In Bergener & Reisberg (Eds) Diagnosis and treatment of senile dementia, pp 374–381, Springer-Verlag, Berlin, Heidelberg, 1989 Schmidt JF, Waldemar G, Paulson OB. The acute effect of nimodipine on cerebral blood flow, its CO2 reacitivity, and cerebral oxygen metabolism in human volunteers. Acta Neurochirurgica 111: 49–53, 1991 Schmidt JF, Waldemar G. Effect of nimodipine on cerebral blood flow in human volunteers. Journal of Cardiovascular Pharmacology 16: 568–571, 1990 Schuurman T, Traber J. Old rats as an animal model for senile dementia: behavioural effects of nimodipine. In Bergener & Reisberg (Eds) Diagnosis and treatment of senile dementia, pp 296–307, Springer-Verlag, Berlin, Heidelberg, 1989 Scriabine A, van der Kerckhoff W. Pharmacology of nimodipine: a review. Annals of the New York Academy of Science 522: 698–706, 1988 Scriabine A, Schuurman T, Traber J. Pharmacological basis for the use of nimodipine in central nervous system disorders. FASEB Journal 3(7): 1799–1806, 1989 Siesjö BK. Calcium in the brain under phsyiological and pathological conditions. European Neurology 30 (Suppl. 2): 3–9, 1990 Stullken Jr EH, Balestrieri FJ, Prough DS, McWhorter JM. The hemodynamic effects of nimodipine in patients anesthetized for cerebral aneurysm clipping. Anesthesiology 62(3): 346–348, 1985 Talley PW, Sundt Jr TM, Anderson RE. Improvement of cortical perfusion, intracellular pH, and electrocorticography by nimodipine during transient focal cerebral ischaemia. Neurosurgery 24: 80–87, 1989 Takayasu M, Bassett JE, Dacey Jr RG. Effects of calcium antagonists on intracerebral penetrating arterioles in rats. Journal of Neurosurgery 69: 104–109, 1988 Tedeschi D. Calcium regulation in brain aging by nimodipine: a multicenter trial in Italy. Current Therapeutic Research 50: 553–563, 1991 Tettenborn D, Dycka J. Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage. Stroke 21 (Suppl. IV): 85–89, 1990 Tettenborn D, Dycka J, Kurtz N, Porto L. Safety profile of nimodipine in patients with subarachnoid hemorrhage. In Scriabine et al. (Eds) Nimodipine. Pharmacological and clinical results in cerebral ischaemia, pp 111–123, Springer-Verlag, Berlin, Heidleberg, 1991 Tobares N, Pedromingo A, Bigorra J. Nimodipine treatment improves cognitive functions in vascular dementia. In Bergener & Reisberg (Eds) Diagnosis and treatment of senile dementia, pp. 360–365, Springer-Verlag, Berlin, Heidelberg, 1989 Tollefson GD. Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia. Biological Psychiatry 27: 1133–1142, 1990 Towart R, Wehinger E, Meyer H, Kazda S. The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle. Arzneimittel-Forschung 32(I): 338–346, 1982 Trust Study Group. Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet 336: 1205–1209, 1990 Uematsu D, Greenberg JH, Hickey WF, Reivich M. Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke 20: 1531–1537, 1989 Ulrich U. Effect of nimodipine upon the topographical distribution of absolute alpha-power in EEG and the actual state of well-being of healthy volunteers. Arzneimittel-Forschung 37(1): 541–544, 1987 Ulrich G, Stieglitz RD. Effect of nimodipine upon electroencephalographic vigilance in elderly persons with minor impairment of brain functions. Arzneimittel-Forschung 38(I): 392–396, 1988 Vinall PE, Michele JJ, Gordon DA, Simeone FA. Comparison of intraluminally versus extraluminally administered nimodipine on serotonin-induced cerebral vascular responses in vitro and in situ. Stroke 20: 1065–1070, 1989 Vinge E, Andersson K-E. Brandt L, Ljunggren B, Nilsson L-G, et al. Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage. European Journal of Clinical Pharmacology 30: 421–425, 1986 Welty TE, Horner TG. Physiology and treatment of subarachnoid hemorrhage. Clinical Pharmacy 9: 35–39, 1990 Wronski J, Abraszko R, Berny W, Mierzwa T. Clinical experiences with nimodipine treatment in patients after SAH and aneurysm surgery. Zentrablatt für Neurochirugie 51: 21–23, 1990 Xie Y, Seo K, Ishimaru K, Hossmann K-A. Effect of calcium antagonists on postischemic protein biosynthesis in gerbil brain. Stroke 23: 87–92, 1992